Document is current
Any future updates will be listed below
-
Authors
Dugan, Michelle M.
Balsay-Patel, Caitlyn
Chin, Nicholas
Tsai, Kenneth Y.
Zager, Jonathan S. https://orcid.org/0000-0002-6886-4468
- License Information
-
More Information
Article History
Received: 27 October 2025
Accepted: 28 October 2025
First Online: 8 November 2025
Disclosure
: Dr. Michelle M. Dugan, Dr. Caitlyn Balsay-Patel, and Nicholas Chin have no conflicts of interest or financial ties to disclose. Dr. Kenneth Y. Tsai has consulting agreements with Verrica Pharmaceuticals, Senhwa Biosciences, NFlection Therapeutics, and Almirall, and has received research funding from Incyte Corporation and Merck. Dr. Jonathan S. Zager has received payments from Delcath Systems Medical Advisory Board and has consulting agreements with Philogen, Merit Medical, Castle Biosciences, Skyline DX, and Merck. His department receives research funding from Philogen, SWOG, and Delcath Systems.
